25 May 2013
Keywords: pericor, s-p, activate, acadesine, deal, new, york
Article | 03 September 2007
New York, USA-based biopharmaceutical firm PeriCor Therapeutics says that its acadesine licensing agreement with Schering Plough has become effective. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.